Enzychem Lifesciences corporation

Company Description

Enzychem Lifesciences corporation Global New Drug Development Company. We have EC-18, our leading compound to treat chemotherapy-induced neutropenia and thrombocytopenia. EC-18 is a non-protein small molecule and oral first-in-class drug as a supplemental drug for most cancer drugs.

We are a functional health food company. We have ROCKPID, the world's first patented immune-modulatory functional health food (FHF), which was approved by the Korean FDA in December 2013.

We also develop and manufacture generic APIs (active pharmaceutical ingredients) such as cephalosporin antibiotics, anti-tuberculosis, anti-coagulant, analgesic, and so on.

Company Information

  • Contact Person:Mr. Jake Lee
  • Telephone:
  • Zip:305-732
  • Province/State:Chungcheongbuk-do
  • City:Daejeon
  • Operational Address:59 Bio Valley-ro, Jecheon-si, Chungcheongbuk-do, South Korea
  • Business Type:Manufacturer, Buying Office, Distributor/Wholesale
  • Year Established:1999
  • Number Of Employees:51 - 100 People
  • Trade Capacity:- -
  • Production Capacity:- -
  • Main Products:D-Cycloserine, Terizidone, Erdosteine,Cefotiam,Cefazedone,
  • Address:F741 KAIST-ICC, 193 Munji-ro
  • Location:Chungcheongbuk-do, South Korea
  • Website:Visit website

Product

  • Non-Cephalosporin
  • Cephalosporin
  • Terizidone
  • D-Cycloserine
  • Cosmetic Ingredients
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries